Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP) announced that the European Commission has granted Orphan Designation in the European Union for the Company’s novel synthetic oral endocannabinoid-mimetic drug, Resunab, for the treatment of cystic fibrosis (“CF”). Read more >>
XCOR’s aim is for daily space flights. Watch this interview with XCOR founder Jeff Greason. Watch now >>
Corbus Pharmaceuticals Holdings, Inc. (CRBP), a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced today that it has completed the Phase 2 study evaluating Resunab for the treatment of diffuse cutaneous systemic sclerosis (“systemic sclerosis”). Corbus expects to report topline data from this study in the fourth quarter of 2016. Read more >>
With a high-speed camera that live-streams video, goggles give visually impaired users a new look at lifeZiad
Alex Curtis’ grandchildren think the thick goggles make him look like a spaceman. With the dark lenses and the cord snaking down to a set of dials and controls, the device does look futuristic.
But what people see when Curtis wears the eSight device doesn’t matter to him. Read more >>
A mother in Wisconsin hopes to one day be able to read to her children. Right now, it’s difficult for her to do that since she is legally blind.
Stephanie Geiger from Grand Chute was diagnosed with Cone Rod Dystrophy at the age of 24. It’s difficult for her to see depth perception, certain colors, and details.
Recently, she got to try out eSight eyewear which uses high optics and resolution procession to improve eye sight. […]
Sean Ainsworth, the CEO of Ann Arbor-based RetroSense Therapeutics LLC, will be honored as entrepreneur of the year Thursday night at TechTown Detroit’s annual Toast of the Town awards program. Read more >>
Corbus Pharmaceuticals Holdings, Inc. (CRBP) a clinical stage drug development company targeting rare, chronic and serious inflammatory and fibrotic diseases, announced that Professor Derek Gilroy, Ph.D. presented data on the effects of Resunab in a model of inflammation in healthy volunteers on September 28, 2016. The presentation was made at the 6th European Workshop on Lipid Mediators at Goethe University in Frankfurt am Main, Germany. Read more >>
For 30-year-old Michael Stanek , the chance to see is “overwhelmingly generous.”
A fundraiser for Michael, who has been legally blind from birth, will be held from 1 to 8 p.m. Sunday at the Ashley Fireman’s Park on Ashley Street.
“To think people would do something like that,” Michael said of the event organizers, expressing his gratefulness.
Organizers look to raise $15,000 to allow Michael the chance to buy eSight — a high-tech eyewear device that enhances whatever the user is looking […]
An Independence family is working to raise money so they can get new technology that will help a legally blind boy see.
Corbin Wolfe has been through a lot in his seven years of life. He was a mini preemie, born weighing 1 pound, 14 ounces. He’s had 86 surgeries.
“He’s a miracle,” his mom, Jennie Braden, said.
Braden found eSight while researching online. The company came to Kansas City to do a demo, and the results stunned her. Read more >>